BIOGAIA AB |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 127.1 SEK | +2.91% |
|
+3.25% | +25.59% |
| Jun. 05 | BioGaia AB Establishes Its Own Distribution in Australia and New Zealand | CI |
| May. 07 | Nordic Shares Closed Up Tuesday; Storskogen Group Series B Topped Leaders | DJ |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Capitalization 1 | 7,359 | 10,846 | 10,462 | 8,439 | 10,219 | 12,835 | - |
| Enterprise Value (EV) 1 | 7,145 | 9,378 | 8,977 | 6,951 | 8,665 | 11,573 | 11,859 |
| P/E ratio | 39.3 x | 53.3 x | 53.3 x | 22.6 x | 28 x | 31.1 x | 28.8 x |
| Yield | 0.88% | 0.64% | 0.7% | 1.74% | 1.88% | 5.43% | 5.43% |
| Capitalization / Revenue | 9.58 x | 14.5 x | 13.3 x | 7.64 x | 7.88 x | 8.91 x | 8.02 x |
| EV / Revenue | 9.3 x | 12.6 x | 11.4 x | 6.3 x | 6.68 x | 8.03 x | 7.41 x |
| EV / EBITDA | 27.7 x | 37.7 x | 31.9 x | 18 x | 18.5 x | 22.1 x | 20.5 x |
| EV / FCF | 61,844,893 x | 45,704,120 x | 41,657,791 x | - | - | - | - |
| FCF Yield | 0% | 0% | 0% | - | - | - | - |
| Price to Book | 14.5 x | 5.49 x | 5.57 x | 4.28 x | 5.03 x | 7.35 x | 8.59 x |
| Nbr of stocks (in thousands) | 86,682 | 100,982 | 100,982 | 100,982 | 100,982 | 100,982 | - |
| Reference price 2 | 84.90 | 107.4 | 103.6 | 83.57 | 101.2 | 127.1 | 127.1 |
| Announcement Date | 2/6/20 | 2/4/21 | 2/4/22 | 2/3/23 | 2/7/24 | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net sales 1 | 768.3 | 747.1 | 785.1 | 1,104 | 1,297 | 1,441 | 1,600 |
| EBITDA 1 | 258.1 | 248.7 | 281 | 385.3 | 468.4 | 523.9 | 578.8 |
| EBIT 1 | 242.5 | 228.2 | 253.7 | 361.5 | 443.1 | 497.6 | 551.2 |
| Operating Margin | 31.56% | 30.54% | 32.31% | 32.74% | 34.18% | 34.54% | 34.46% |
| Earnings before Tax (EBT) 1 | 242.3 | 227.6 | 252.7 | 447.6 | 468.8 | 525.6 | 571.2 |
| Net income 1 | 187.3 | 179.7 | 196.3 | 373.6 | 365.4 | 412.6 | 445.5 |
| Net margin | 24.38% | 24.05% | 25% | 33.84% | 28.18% | 28.64% | 27.85% |
| EPS 2 | 2.162 | 2.014 | 1.944 | 3.700 | 3.620 | 4.090 | 4.410 |
| Free Cash Flow | 115.5 | 205.2 | 215.5 | - | - | - | - |
| FCF margin | 15.04% | 27.46% | 27.45% | - | - | - | - |
| FCF Conversion (EBITDA) | 44.76% | 82.51% | 76.69% | - | - | - | - |
| FCF Conversion (Net income) | 61.69% | 114.18% | 109.78% | - | - | - | - |
| Dividend per Share 2 | 0.7500 | 0.6820 | 0.7260 | 1.450 | 1.900 | 6.900 | 6.900 |
| Announcement Date | 2/6/20 | 2/4/21 | 2/4/22 | 2/3/23 | 2/7/24 | - | - |
1SEK in Million2SEK
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q4 | 2022 Q2 | 2022 Q3 |
|---|---|---|---|
| Net sales 1 | 206.2 | 288.1 | 257.7 |
| EBITDA 1 | 58.22 | 107.4 | 98.85 |
| EBIT 1 | 53.1 | 101.3 | 93.74 |
| Operating Margin | 25.75% | 35.16% | 36.37% |
| Earnings before Tax (EBT) 1 | 52.63 | 99 | 98.8 |
| Net income 1 | 38.3 | 78.54 | 79.5 |
| Net margin | 18.57% | 27.26% | 30.85% |
| EPS 2 | 0.3800 | 0.7800 | 0.7900 |
| Dividend per Share | - | - | - |
| Announcement Date | 2/4/22 | 7/22/22 | 10/21/22 |
1SEK in Million2SEK
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - |
| Net Cash position 1 | 214 | 1,468 | 1,485 | 1,488 | 1,554 | 1,262 | 976 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - |
| Free Cash Flow | 116 | 205 | 215 | - | - | - | - |
| ROE (net income / shareholders' equity) | 37% | 16% | 10.8% | 19.4% | 18.3% | 21.9% | 27.5% |
| ROA (Net income/ Total Assets) | - | - | - | - | - | - | - |
| Assets 1 | - | - | - | - | - | - | - |
| Book Value Per Share 2 | 5.860 | 19.60 | 18.60 | 19.50 | 20.10 | 17.30 | 14.80 |
| Cash Flow per Share | 1.710 | 2.190 | 2.200 | - | - | - | - |
| Capex 1 | 32.3 | 16.1 | 6.38 | 17.9 | 48.6 | 35 | 36.8 |
| Capex / Sales | 4.21% | 2.15% | 0.81% | 1.62% | 3.75% | 2.43% | 2.3% |
| Announcement Date | 2/6/20 | 2/4/21 | 2/4/22 | 2/3/23 | 2/7/24 | - | - |
1SEK in Million2SEK
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
127.1
SEK
Average target price
150
SEK
Spread / Average Target
+18.02%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +25.59% | 1.18B | |
| +7.46% | 101B | |
| +8.42% | 42.18B | |
| -13.04% | 32.26B | |
| +80.80% | 29.79B | |
| -10.92% | 16.06B | |
| +1.93% | 14.45B | |
| -6.77% | 12.01B | |
| +177.16% | 10.71B | |
| +4.12% | 8.89B |
- Stock Market
- Equities
- BIOG B Stock
- Financials BioGaia AB
